Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arjun Nair

Showing results (111-120 of 121) with videos related to

Pageof 13
Sort By:
American Journal of Respiratory and Critical Care Medicine|April 24, 2018
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic AnalysisJoseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
Health Technology Assessment (Winchester, England)|May 26, 2016
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancerJohn K Field, Stephen W Duffy, David R Baldwin, et al.
ERJ Open Research|August 26, 2021
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysemaAn Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
Cytotherapy|April 3, 2026
A first-in-human phase I clinical trial investigating the safety and efficacy of repeat dosing MSCTRAIL cell therapy in addition to chemotherapy and immunotherapy in patients with advanced lung cancerRebecca N Graham, Alice Davies, Monica L Mullin, et al.
The Lancet. Oncology|May 4, 2023
Defining the road map to a UK national lung cancer screening programmeEmma L O'Dowd, Richard W Lee, Ahsan R Akram, et al.
BMJ Open Respiratory Research|September 11, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screeningBrintha Selvarajah, Amyn Bhamani, Mehran Azimbagirad, et al.
The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.
The Lancet. Oncology|March 28, 2025
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese, et al.
ERJ Open Research|April 3, 2023
Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosisEyjolfur Gudmundsson, An Zhao, Nesrin Mogulkoc, et al.
The European Respiratory Journal|November 16, 2023
Mortality surrogates in combined pulmonary fibrosis and emphysemaAn Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
Pageof 13

Showing results (111-120 of 121) with videos related to

Sort By:
Pageof 13
American Journal of Respiratory and Critical Care Medicine|April 24, 2018
Predicting Outcomes in Idiopathic Pulmonary Fibrosis Using Automated Computed Tomographic AnalysisJoseph Jacob, Brian J Bartholmai, Srinivasan Rajagopalan, et al.
Health Technology Assessment (Winchester, England)|May 26, 2016
The UK Lung Cancer Screening Trial: a pilot randomised controlled trial of low-dose computed tomography screening for the early detection of lung cancerJohn K Field, Stephen W Duffy, David R Baldwin, et al.
ERJ Open Research|August 26, 2021
Mortality in combined pulmonary fibrosis and emphysema patients is determined by the sum of pulmonary fibrosis and emphysemaAn Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
Cytotherapy|April 3, 2026
A first-in-human phase I clinical trial investigating the safety and efficacy of repeat dosing MSCTRAIL cell therapy in addition to chemotherapy and immunotherapy in patients with advanced lung cancerRebecca N Graham, Alice Davies, Monica L Mullin, et al.
The Lancet. Oncology|May 4, 2023
Defining the road map to a UK national lung cancer screening programmeEmma L O'Dowd, Richard W Lee, Ahsan R Akram, et al.
BMJ Open Respiratory Research|September 11, 2025
Differentiating clinically important interstitial lung abnormalities in lung cancer screeningBrintha Selvarajah, Amyn Bhamani, Mehran Azimbagirad, et al.
The Lancet Regional Health. Europe|November 22, 2021
Lung cancer mortality reduction by LDCT screening: UKLS randomised trial results and international meta-analysisJohn K Field, Daniel Vulkan, Michael P A Davies, et al.
The Lancet. Oncology|March 28, 2025
Low-dose CT for lung cancer screening in a high-risk population (SUMMIT): a prospective, longitudinal cohort studyAmyn Bhamani, Andrew Creamer, Priyam Verghese, et al.
ERJ Open Research|April 3, 2023
Delineating associations of progressive pleuroparenchymal fibroelastosis in patients with pulmonary fibrosisEyjolfur Gudmundsson, An Zhao, Nesrin Mogulkoc, et al.
The European Respiratory Journal|November 16, 2023
Mortality surrogates in combined pulmonary fibrosis and emphysemaAn Zhao, Eyjolfur Gudmundsson, Nesrin Mogulkoc, et al.
Pageof 13